Kalyani Daita

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.

Altered profile of human gut microbiome is associated with cirrhosis and its complications.

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus.

Erratum: Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus.

Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese.

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer.

Preserved hemostatic status in patients with non-alcoholic fatty liver disease.